Clopidogrel Tad vs Iscover: Side-by-Side Comparison
Quick answer: Clopidogrel Tad and Iscover are both antiplatelet (p2y12 inhibitor) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Clopidogrel Tad | Iscover |
|---|---|---|
| Drug class | Antiplatelet (P2Y12 inhibitor) | Antiplatelet (P2Y12 inhibitor) |
| ATC code | B01AC04 | B01AC04 |
| Primary indications | Acute coronary syndrome, Secondary prevention after MI/stroke | Acute coronary syndrome, Secondary prevention of atherothrombotic events |
| Mechanism | Irreversibly inhibits the platelet P2Y12 ADP receptor, preventing platelet aggregation | Clopidogrel, an irreversible P2Y12 ADP receptor antagonist that inhibits platelet aggregation |
| Common dose | 75 mg once daily (300-600 mg loading dose) | 75 mg once daily (300-600 mg loading dose) |
| Detail page | Clopidogrel Tad details → | Iscover details → |
How to choose between Clopidogrel Tad and Iscover
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Antiplatelet (P2Y12 inhibitor) on iMedic · Clopidogrel Tad full details · Iscover full details
Frequently asked questions
Is Clopidogrel Tad better than Iscover?
Neither is universally 'better.' They are both antiplatelet (p2y12 inhibitor) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Clopidogrel Tad to Iscover?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Clopidogrel Tad and Iscover have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Clopidogrel Tad and Iscover available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.